Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BYFrontiers in oncology

Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB-IIIC cervical cancer: a single-center retrospective study.

  1. 1Department of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.

Abstract

Background

Currently, whether surgical staging can confer a survival benefit in patients with cervical cancer remains controversial, and its efficacy is similarly uncertain across different subgroups. The primary aim of this study was to assess the efficacy of laparoscopic para-aortic and pelvic lymphadenectomy prior to chemoradiotherapy in patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIB-IIIC cervical cancer. The secondary aim was to identify the main prognostic factors.Methods

A total of 396 patients were included in this retrospective study, 97 patients who underwent laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy comprised the surgical staging group, and 299 patients who received chemoradiotherapy alone comprised the clinical staging group. Kaplan-Meier and log-rank methods were used to construct and compare progression-free survival (PFS) and overall survival (OS) curves, respectively. Multivariable Cox proportional hazards regression models were used to identify independent prognostic factors.Results

There were no statistically significant differences in PFS (p = 0.187) or OS (p = 0.490) between the two groups. The estimated 5-year PFS rates were 67.0% (95%CI, 56.9%-75.7%) in the surgical staging group and 73.6% (95%CI, 67.4%-78.7%) in the clinical staging group. The corresponding 5-year OS rates were 76.3% (95%CI, 66.0%-83.9%) and 78.6% (95%CI, 72.7%-83.2%), respectively. Subgroup analysis stratified by imaging lymph node status demonstrated comparable survival outcomes. Multivariate analysis identified adenocarcinoma, pelvic wall involvement, and imaging-positive lymph nodes as independent risk factors for PFS; adenocarcinoma, adenosquamous carcinoma, pelvic wall involvement, and imaging-positive lymph nodes were independent predictors of OS.Conclusions

Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved PFS or OS in this retrospective cohort, Tumor histology, pelvic wall involvement, and imaging-positive lymph nodes were the main prognostic factors.

Related

  1. Short-Term Outcomes and Stoma-Related Morbidity of Diverting Ileostomy After Laparoscopic Total Mesorectal Excision Following Neoadjuvant Chemoradiotherapy for Mid- and Distal Rectal Cancer: A Retrospective Single-Center Study
    Murat Derebey, Ufuk Karabacak, Ismail Alper Tarim +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Preoperative ovarian vascular parameters and perioperative factors associated with ovarian reserve marker decline after laparoscopic endometrioma cystectomy: a retrospective prediction study
    Mengmeng Wu, Mei Qin, Linrui Zhang
    Frontiers in SurgeryPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsPMC
  4. Salvage nivolumab plus temozolomide associated with improved survival and clinical benefit in refractory melanoma: a retrospective cohort study
    Preethy E. Abraham, Kun Bai, Sheau-Chiann Chen +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  5. R0 resection following neoadjuvant PD-1 inhibition with paclitaxel-cisplatin is associated with improved overall survival in locally advanced and recurrent oral squamous cell carcinoma: multicenter retrospective cohort study.
    Qiwei Wang, Yan Liu, Liang Zuo +10
    Annals of medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMC
BibTeX
@article{zhang2026laparoscopic,
  title = {{Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB-IIIC cervical cancer: a single-center retrospective study.}},
  author = {Qin Zhang and Lin Li and Xiuying Li and Dongling Zou},
  journal = {Frontiers in oncology},
  year = {2026},
  month = oct,
  doi = {10.3389/fonc.2026.1975884},
  url = {https://europepmc.org/article/MED/42908783},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB-IIIC cervical cancer: a single-center retrospective study.
AU  - Qin Zhang
AU  - Lin Li
AU  - Xiuying Li
AU  - Dongling Zou
PY  - 2026
DA  - 2026/10/07
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1975884
UR  - https://europepmc.org/article/MED/42908783
AB  - Background  Currently, whether surgical staging can confer a survival benefit in patients with cervical cancer remains controversial, and its efficacy is similarly uncertain across different subgroups. The primary aim of this study was to assess the efficacy of laparoscopic para-aortic and pelvic lymphadenectomy prior to chemoradiotherapy in patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIB-IIIC cervical cancer. The secondary aim was to identify the main prognostic factors.Methods  A total of 396 patients were included in this retrospective study, 97 patients who underwent laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy comprised the surgical staging group, and 299 patients who received chemoradiotherapy alone comprised the clinical staging group. Kaplan-Meier and log-rank methods were used to construct and compare progression-free survival (PFS) and overall survival (OS) curves, respectively. Multivariable Cox proportional hazards regression models were used to identify independent prognostic factors.Results  There were no statistically significant differences in PFS (p = 0.187) or OS (p = 0.490) between the two groups. The estimated 5-year PFS rates were 67.0% (95%CI, 56.9%-75.7%) in the surgical staging group and 73.6% (95%CI, 67.4%-78.7%) in the clinical staging group. The corresponding 5-year OS rates were 76.3% (95%CI, 66.0%-83.9%) and 78.6% (95%CI, 72.7%-83.2%), respectively. Subgroup analysis stratified by imaging lymph node status demonstrated comparable survival outcomes. Multivariate analysis identified adenocarcinoma, pelvic wall involvement, and imaging-positive lymph nodes as independent risk factors for PFS; adenocarcinoma, adenosquamous carcinoma, pelvic wall involvement, and imaging-positive lymph nodes were independent predictors of OS.Conclusions  Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved PFS or OS in this retrospective cohort, Tumor histology, pelvic wall involvement, and imaging-positive lymph nodes were the main prognostic factors.
SN  - 2234-943X
ER  -